Genomic Applications Partnership Program (GAPP)

Overview of the Genomic Applications Partnership Program (GAPP) program:

GAPP focuses on funding downstream research and development (R&D) projects that apply genomics-derived tools, products, or processes to address specific needs defined by receptor organizations. These projects are typically in the late stages of R&D, positioning innovations for near-term implementation or commercialization. The program emphasizes partnerships where both academic researchers and receptor organizations play active and necessary roles, ensuring that the solutions developed are both scientifically robust and practically applicable.

Benefits of the Genomic Applications Partnership Program (GAPP) program:

• Accelerated Innovation: Facilitates the rapid application of genomics solutions to address industry-specific challenges.
• Collaborative Partnerships: Promotes collaboration between academic researchers and receptor organizations, enhancing knowledge exchange.
• Economic and Social Impact: Aims to generate significant benefits for Canadian society and the economy through applied genomics.
• De-risking Investment: Enhances the value of Canadian genomics technologies, incentivizing further investment from industry partners.

Eligibility criteria of the Genomic Applications Partnership Program (GAPP) program:

• To qualify for GAPP funding, projects must:
• Develop and Apply Genomics Solutions: Focus on applying genomics-derived or enabling solutions to challenges defined by receptor organizations.
• Late-Stage R&D: Engage in research positioning the innovation for near-term implementation or commercialization.
• Collaborative Leadership: Be co-led by an academic researcher and a receptor organization, with both playing active and necessary roles.
• Canadian Benefit: Demonstrate potential to generate significant social and/or economic benefits for Canada.